Baidu
map

National Science Review: 卞修武/张定宇等发现新冠肺炎患者的新型病理特征

2020-10-04 椰子 iNature

由于新病例的迅速增加,冠状病毒病很快引起了全球关注,病原体被鉴定为SARS-CoV-2。截至目前,据约翰·霍普金斯大学发布的实时统计数据,全球累计新冠肺炎确诊病例超过3495万,死亡人数达103万。

由于新病例的迅速增加,2019年冠状病毒病(COVID-19)很快引起了全球关注,病原体被鉴定为SARS-CoV-2。截至目前(10月4日),据约翰·霍普金斯大学发布的实时统计数据,全球累计新冠肺炎确诊病例超过3495万例,死亡人数达103万。这些数字每天都会更新,而且预计还会进一步增加。 尽管临床观察支持大多数重症COVID-19患者表现出严重的免疫疾病,这可能会导致肺部和多个肺外器官的损害,但是脾脏和淋巴结还没有被充分研究。

2020年9月30日,华中科技大学,空军军医大学,上海交通大学等多单位合作,卞修武,刘良,张定宇,王朝夫等共同通讯在National Science Review 在线发表题为“Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases ”的研究论文,该研究报告了12名COVID-19死者的肺和淋巴器官的尸检结果,对这些死者评估了肺,脾和淋巴结的组织病理学变化,免疫细胞标记和炎性因子表达。

该研究发现肺部主要的改变包括弥漫性肺泡损伤,间质纤维化和渗出性炎症,其特征是广泛的浆液和纤维蛋白渗出液,巨噬细胞浸润以及炎性因子(IL-6,IP-10,TNFα和IL-1β) 的大量产生。脾脏和肺门淋巴结中含有组织结构破坏和免疫细胞失调的病变,包括淋巴细胞减少症和巨噬细胞积累。这些发现提供了病理证据,将重症COVID-19患者的肺部和淋巴器官损伤与致命的系统性呼吸道和免疫功能障碍联系在一起。

由于新病例的迅速增加,2019年冠状病毒病(COVID-19)很快引起了全球关注。新型冠状病毒感染被认为是从动物传播的,病原体被鉴定为SARS-CoV-2。到2020年1月,怀疑最初受感染的患者是通过人与人之间的传播感染了该病毒。自2020年1月以来,该病毒已迅速传播到中国大部分地区和其他国家。

由于新病例的迅速增加,2019年冠状病毒病(COVID-19)很快引起了全球关注,病原体被鉴定为SARS-CoV-2。截至目前(10月4日),据约翰·霍普金斯大学发布的实时统计数据,全球累计新冠肺炎确诊病例超过3495万例,死亡人数达103万。这些数字每天都会更新,而且预计还会进一步增加。

尽管COVID-19通常是一种以肺炎为特征的急性自限性疾病,但大约15%的COVID-19患者(尤其是那些年龄较大且已有疾病的患者)可以迅速发展为致命的系统性疾病,例如急性呼吸窘迫综合征和 严重的血管或肾脏损伤,其中5%-6%的病例可能发展为危急状态,死亡率很高。

因此,已对COVID-19的病毒学,流行病学和临床特征进行了广泛研究,并对临床特征进行了分析。然而,与COVID-19相关的病理改变尚待阐明。最近通过对COVID-19死者进行完全尸检或微创尸检的研究,发现SARS-CoV-2劫持了血管紧张素转化酶2(ACE2)进入靶细胞引起肺和多个肺外器官/组织的严重病理变化。

尽管临床观察支持大多数重症COVID-19患者表现出严重的免疫疾病,这可能会导致肺部和多个肺外器官的损害,但是脾脏和淋巴结还没有被充分研究。为了剖析重症COVID-19患者的严重呼吸窘迫综合征和免疫功能低下的病理变化,该研究对12例死者的COVID-19患者进行了系统的尸检和综合病理分析。该研究的发现为与COVID-19相关的病理变化提供了新证据,并提出了针对该疾病的临床方法。

原始出处:

Qian Liu, Yu Shi, Jun Cai,et al.Pathological changes in the lungs and lymphatic organs of twelve COVID-19 autopsy cases .National Science Review, nwaa247, https://doi.org/10.1093/nsr/nwaa247Published: 29 September 2020

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2021-03-05 xugumin
  2. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2021-07-28 liye789132251
  3. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-06 jichang
  5. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-04 公卫新人

    新冠肺炎,疫情何时才能消失

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1995822, encodeId=4a56199582293, content=<a href='/topic/show?id=a1751540260' target=_blank style='color:#2F92EE;'>#review#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15402, encryptionId=a1751540260, topicName=review)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Fri Mar 05 18:26:52 CST 2021, time=2021-03-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1884700, encodeId=414c1884e0079, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=94, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Wed Jul 28 15:26:52 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2033201, encodeId=f6172033201d0, content=<a href='/topic/show?id=c097e104497' target=_blank style='color:#2F92EE;'>#病理特征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=71044, encryptionId=c097e104497, topicName=病理特征)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c279140, createdName=vividelife, createdTime=Fri Oct 23 17:26:52 CST 2020, time=2020-10-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1376182, encodeId=2f4413e618237, content=<a href='/topic/show?id=2949159989d' target=_blank style='color:#2F92EE;'>#SCIE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15998, encryptionId=2949159989d, topicName=SCIE)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=17a3387, createdName=jichang, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1429392, encodeId=12a414293920e, content=<a href='/topic/show?id=75f449945dc' target=_blank style='color:#2F92EE;'>#张定宇#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=105, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=49945, encryptionId=75f449945dc, topicName=张定宇)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5a74186932, createdName=mashirong, createdTime=Tue Oct 06 05:26:52 CST 2020, time=2020-10-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1028616, encodeId=108c102861647, content=新冠肺炎,疫情何时才能消失, beContent=null, objectType=article, channel=null, level=null, likeNumber=91, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=公卫新人, createdTime=Sun Oct 04 17:26:52 CST 2020, time=2020-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=890084, encodeId=988789008444, content=无止境啊!, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKibA62IFMeUJEmSyIe8DvYFeERuOsfrRd8iano7nENqQU1dRR3tqeQOUL3eqgYgEZRT2t2iaEsib0JEw/132, createdBy=66771693911, createdName=易水河, createdTime=Sun Oct 04 14:42:41 CST 2020, time=2020-10-04, status=1, ipAttribution=)]
    2020-10-04 易水河

    无止境啊!

    0

相关资讯

Lancet:36个国家213家医院:采用ECMO支持的新冠肺炎患者的死亡率

新冠肺炎仍在肆虐全球,每天关注的不仅新增多少,还有重症患者增加了多少。在国外疫情爆发时,体外膜肺氧合(ECMO)机器炙手可热。ECMO为重症患者提供了一线生机,这一线生机到底有多少呢?

N Engl J Med :张锋首次发表NEJM论文,发布升级版SHERLOCK系统,加速新冠检测

2020年2月14日,CRISPR基因编辑大神张锋教授团队发布了使用基于CRISPR/Cas13的SHERLOCK技术检测新型冠状病毒的详细操作流程文档。

再生元抗体鸡尾酒REGN-COV2治疗特朗普新冠病毒感染,研究数据全在这里!

2020年9月29日,再生元公布新冠治疗抗体鸡尾酒REGN-COV2治疗非住院患者的积极临床数据。REGN-COV2可以显著降低病毒滴度,改善临床症状。

“第二波”要来了?快讯:我国多地新增境外输入新冠感染者!福奇称我们本可以真正阻止新冠疫情暴发

世卫组织网站最新数据显示,截至欧洲中部时间24日17时05分(北京时间23时05分),全球确诊病例较前一日增加284531例,达到31664104例;死亡病例增加5802例,达到972221例。

Sci Rep:如何应对新冠二次暴发?新研究通过预测模型成功模拟欧洲二次疫情发展形势

第一次新冠疫情爆发很大程度上在于事发突然,许多防控措施无法及时实施。如今,面临二次疫情的威胁,人类是否能基于现有的数据对新冠疫情发展进行预测,从而避免或减少疫情二次冲击造成的损失呢?

FDA全新报告: 帝基生物新冠病毒检测产品名列前茅

DiaCarta (帝基生物)试剂盒是唯有几家通过考核能保持原先申报高灵敏度的厂家。

Baidu
map
Baidu
map
Baidu
map